Market revenue in 2023 | USD 202.8 million |
Market revenue in 2030 | USD 440.5 million |
Growth rate | 11.7% (CAGR from 2023 to 2030) |
Largest segment | Laboratory testing |
Fastest growing segment | Laboratory Testing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Laboratory Testing |
Key market players worldwide | Alcami, Merck KGaA, Eurofins Scientific SE, Agilent Technologies Inc, Charles River Laboratories International Inc, Catalent Inc, Avomeen Analytical Services, Pace Analytical Services, Sotera Health Co Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceuticals manufacturing consumables testing market will help companies and investors design strategic landscapes.
Laboratory testing was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the North America biopharmaceuticals manufacturing consumables testing market based on laboratory testing covering the revenue growth of each sub-segment from 2018 to 2030.
The North America accounts for the largest market share. The local companies are involved in strategic acquisitions, which have supported high inorganic revenue growth in the market. For example, in June 2016, Charles River Laboratories International, Inc. acquired Blue Stream Laboratories, Inc. to strengthen its existing discovery, safety assessment, and biologics development capabilities.
This initiative was intended to boost the company’s biosimilar and biologic development capabilities, ranging from characterization to clinical testing and commercialization. Various seminars and conferences, intended to boost final product success, are conducted in the region to help understand the requirements of raw material testing in a cGMP environment.
The regulatory bodies have played a vital role in reshaping the biopharmaceutical manufacturing consumables market in this region. Regulatory agencies, like Health Canada and FDA, have set pharmacopoeia standards to maintain the quality of excipients used in product formulations.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America biopharmaceuticals manufacturing consumables testing market , including forecasts for subscribers. This continent databook contains high-level insights into North America biopharmaceuticals manufacturing consumables testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account